BioStock: Respiratorius secures additional patent

Respiratorius has secured its second patent for the drug candidate VAL001, a new oral formulation of sodium valproate for the treatment of cancer. The company thus adds another important piece to the puzzle that will strengthen the project in the ongoing partnering, where discussions are currently underway with potential takers.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/10/respiratorius-secures-additional-patent/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se